Raghav Pawan Kumar, Mann Zoya
Immunogenetics and Transplantation Laboratory, Department of Surgery, University of California San Francisco (UCSF), San Francisco, CA 94118, USA.
BioExIn, Delhi 110032, India.
Biomedicines. 2024 Dec 9;12(12):2791. doi: 10.3390/biomedicines12122791.
Stem cell transplantation has proven effective in treating acute and chronic wounds, but its limitations, such as low cellular viability and the need for specialized transportation, highlight the necessity for alternative approaches. This review explores the potential of engineered exosomes, containing identified miRNAs/peptides, as a more stable and efficient cell-free therapy for regenerative medicine, particularly in wound healing. The discussion emphasizes the benefits of exosomes, including their stability, reduced damage, and consistent biological activity, paving the way for innovative applications like lyophilized exosomes, mist spray delivery, and exosome-based scaffolds. The exploration of cell-free therapy in this review holds promising implications for advancing wound-healing strategies.
干细胞移植已被证明在治疗急慢性伤口方面有效,但其局限性,如细胞活力低和需要专门运输,凸显了采用替代方法的必要性。本综述探讨了含有已鉴定的微小RNA/肽的工程化外泌体作为再生医学中一种更稳定、更有效的无细胞疗法的潜力,特别是在伤口愈合方面。讨论强调了外泌体的益处,包括其稳定性、损伤减少和一致的生物活性,为冻干外泌体、喷雾递送和基于外泌体的支架等创新应用铺平了道路。本综述中对无细胞疗法的探索对推进伤口愈合策略具有广阔的前景。